Back to Search Start Over

484 - The SGLT2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model.

Authors :
Joubert, M.
Jagu, B.
Montaigne, D.
Maréchal, X.
Tesse, A.
Ayer, A.
Dollet, L.
Le May, C.
Toumaniantz, G.
Manrique, A.
Charpentier, F.
Staels, B.
Magré, J.
Cariou, B.
Prieur, X.
Source :
Archives of Cardiovascular Diseases Supplements; Apr2017, Vol. 9 Issue 2, p171-171, 1p
Publication Year :
2017

Details

Language :
English
ISSN :
18786480
Volume :
9
Issue :
2
Database :
Supplemental Index
Journal :
Archives of Cardiovascular Diseases Supplements
Publication Type :
Academic Journal
Accession number :
124212438
Full Text :
https://doi.org/10.1016/S1878-6480(17)30427-5